I
ISSUER//CIK 0001786255
Icosavax, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D/A73.8 KBIcosavax, Inc.Feb 21, 4:21 PM ET·0001104659-24-026050
- SC 13D/A88.8 KBIcosavax, Inc.Feb 21, 4:17 PM ET·0001104659-24-026047
- 8-K313.3 KBIcosavax, Inc.Feb 20, 8:42 AM ET·0001104659-24-025251
- SC 13G/A138.9 KBIcosavax, Inc.Feb 14, 4:58 PM ET·0001104659-24-023963
- SC 13G67.8 KBIcosavax, Inc.Feb 14, 4:01 PM ET·0000902664-24-001660
- SC 13G6.5 KBIcosavax, Inc.Feb 14, 10:04 AM ET·0001897612-24-001286
- SC 13G3.5 KBIcosavax, Inc.Feb 13, 10:37 AM ET·0001256071-24-000004
- SC 13G/A12.5 KBIcosavax, Inc.Feb 7, 5:09 PM ET·0001086364-24-006830
- SC 13G13.3 KBIcosavax, Inc.Feb 2, 3:57 PM ET·0001086364-24-006292
- SC 13G/A8.2 KBIcosavax, Inc.Jan 10, 8:53 AM ET·0000315066-24-000044
Insiders
10- ADAMS STREET PARTNERS LLC10% Owner
- Balta ElizabethGeneral Counsel & Corp. Sec.
- Cearley CassiaChief Business Officer
- Chen BihuaFormer 10% Owner
- Cormorant Asset Management, LPFormer 10% Owner
- Cormorant Private Healthcare Fund III LPFormer 10% Owner
- FIELDS HEIDIDirector
- Gould Terry PDirector, 10% Owner
- Holtzman DouglasChief Scientific Officer
- Kanesa-thasan NiranjanChief Medical Officer
Tickers
No tickers on record
Addresses
business
1930 BOREN AVE., SUITE 1000
SEATTLE, WA, 98101
mailing
1930 BOREN AVE., SUITE 1000
SEATTLE, WA, 98101